Division of Nephrology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Department of Epidemiology, Columbia University Irving Medical Center, New York, NY, USA.
Transpl Int. 2019 Jun;32(6):646-657. doi: 10.1111/tri.13406. Epub 2019 Feb 28.
While deceased donor renal transplants (DDRT) from donors with either acute kidney injury (AKI) or long cold ischemia time (CIT) are associated with increased risk of delayed graft function (DGF), recipients of these kidneys have good patient and allograft survival. There are limited data on whether kidneys with both AKI and long CIT have outcomes similar to kidneys with only one of these insults. Using data from the Scientific Registry of Transplant Recipients, we analyzed transplant outcomes in patients (2005-2015) receiving kidneys with AKI (terminal creatinine ≥2.0 mg/dl) and CIT 24-30 h (n = 1289), 30-36 h (n = 734), and >36 h (n = 614), using kidneys with AKI and CIT <24 h (n = 5434) as a reference. DGF was more common with increasing CIT up to 36 h, then decreased slightly (41.2% vs. 46.8% vs. 52.5% vs. 50.2%, P < 0.001). Death-censored graft survival (DCGS) at 3 years was better with CIT <24 h compared with other groups (92.5% vs. 90.8% vs. 92% vs. 89.2%, P = 0.018). On multivariable analysis, donor creatinine was predictive of DCGS, whereas only CIT >36 h was predictive of DCGS (aHR 1.27, P = 0.03). Recipients transplanted with kidneys with both AKI and long CIT have excellent intermediate-term outcomes.
虽然来自存在急性肾损伤(AKI)或长冷缺血时间(CIT)的供体的死亡供体肾移植(DDRT)与延迟移植物功能障碍(DGF)的风险增加相关,但这些肾脏的受者具有良好的患者和移植物存活率。关于同时存在 AKI 和长 CIT 的肾脏与仅存在其中一种损伤的肾脏的结局是否相似,数据有限。利用移植受者科学登记处的数据,我们分析了在接受 AKI(终末期肌酐≥2.0 mg/dl)和 CIT 24-30 h(n=1289)、30-36 h(n=734)和>36 h(n=614)的患者(2005-2015 年)中移植结局,以 AKI 和 CIT <24 h 的肾脏(n=5434)作为参考。随着 CIT 增加至 36 h,DGF 更为常见,但随后略有下降(41.2%比 46.8%比 52.5%比 50.2%,P<0.001)。与其他组相比,CIT <24 h 的 3 年死亡风险校正移植物存活率(DCGS)更好(92.5%比 90.8%比 92%比 89.2%,P=0.018)。多变量分析显示,供体肌酐是 DCGS 的预测因素,而只有 CIT >36 h 是 DCGS 的预测因素(aHR 1.27,P=0.03)。同时存在 AKI 和长 CIT 的供肾受者具有出色的中期结局。